Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vebreltinib in Advanced Clear Cell Sarcoma
NCT07153887Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vebreltinib in clear cell sarcoma (CCS), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Sep 2025; status: recruiting.
02
Drugs
vebreltinib
03
Conditions
clear cell sarcoma (CCS)
Beyond the preview
Go deeper on NCT07153887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07153887.